418 related articles for article (PubMed ID: 19180897)
41. [Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
Saito M; Mori A; Irie T; Tanaka M; Morioka M
Rinsho Ketsueki; 2009 Mar; 50(3):192-6. PubMed ID: 19352087
[TBL] [Abstract][Full Text] [Related]
42. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
43. Photosensitive erythema multiforme apparently induced by phenylbutazone.
Leroy D; Le Maitre M; Deschamps P
Photodermatol; 1985 Jun; 2(3):176-7. PubMed ID: 4022817
[No Abstract] [Full Text] [Related]
44. Recall dermatitis after systemic treatment with paclitaxel.
Kazandjieva J; Gergovska M; Darlenski R; Márina S; Broshtilova V; Balabanova M; Stransky L
Int J Dermatol; 2010 Aug; 49(8):956-9. PubMed ID: 21128924
[TBL] [Abstract][Full Text] [Related]
45. Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer.
Dasanu CA; Alexandrescu DT
South Med J; 2008 Nov; 101(11):1161-2. PubMed ID: 19088531
[TBL] [Abstract][Full Text] [Related]
46. Phase II study of weekly paclitaxel as a second-line treatment for S-1-refractory advanced gastric cancer.
Matsuda G; Kunisaki C; Makino H; Fukahori M; Kimura J; Sato T; Oshima T; Nagano Y; Fuii S; Takagawa R; Kosaka T; Ono HA; Akiyama H; Ichikawa Y
Anticancer Res; 2009 Jul; 29(7):2863-7. PubMed ID: 19596975
[TBL] [Abstract][Full Text] [Related]
47. Erythema multiforme photoinduced by statins.
Rodríguez-Pazos L; Sánchez-Aguilar D; Rodríguez-Granados MT; Pereiro-Ferreirós MM; Toribio J
Photodermatol Photoimmunol Photomed; 2010 Aug; 26(4):216-8. PubMed ID: 20626826
[TBL] [Abstract][Full Text] [Related]
48. Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.
Payne JY; Holmes F; Cohen PR; Gagel R; Buzdar A; Dhingra K
South Med J; 1996 May; 89(5):542-5. PubMed ID: 8638189
[TBL] [Abstract][Full Text] [Related]
49. [Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy].
Freites-Martínez A; Martinez-Sánchez D; de Pablo NP; Calderón-Komaromy A; Córdoba S; Burbujo J
Invest Clin; 2014 Mar; 55(1):55-60. PubMed ID: 24758102
[TBL] [Abstract][Full Text] [Related]
50. Erythema multiforme after radiotherapy with aromatase inhibitor administration in breast-conservation treatment for breast cancer.
Nakatani K; Matsumoto M; Ue H; Nishioka A; Tanaka Y; Kodama H; Sasaguri S; Ogawa Y
Breast Cancer; 2008; 15(4):321-3. PubMed ID: 18278432
[TBL] [Abstract][Full Text] [Related]
51. Paclitaxel: a new antimitotic chemotherapeutic agent.
Gotaskie GE; Andreassi BF
Cancer Pract; 1994; 2(1):27-33. PubMed ID: 7914453
[TBL] [Abstract][Full Text] [Related]
52. [A case successfully treated by desensitization for paclitaxel-associated hypersensitivity reactions].
Yamatoya Y; Wada Y; Sato S; Morikawa T; Sakata N; Nakata J; Seki K; Wada N; Kamiyama K; Tominaga T
Gan To Kagaku Ryoho; 2007 Feb; 34(2):271-4. PubMed ID: 17301542
[TBL] [Abstract][Full Text] [Related]
53. Photo-onycholysis due to indapamide.
Rutherford T; Sinclair R
Australas J Dermatol; 2007 Feb; 48(1):35-6. PubMed ID: 17222300
[TBL] [Abstract][Full Text] [Related]
54. Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma.
Bilaç C; Müezzinoğlu T; Ermertcan AT; Kayhan TC; Temeltaş G; Oztürkcan S; Temiz P
Cutan Ocul Toxicol; 2009; 28(2):90-2. PubMed ID: 19514932
[TBL] [Abstract][Full Text] [Related]
55. Radiation recall dermatitis from docetaxel.
Piroth MD; Krempien R; Wannenmacher M; Zierhut D
Onkologie; 2002 Oct; 25(5):438-40. PubMed ID: 12415198
[TBL] [Abstract][Full Text] [Related]
56. Photosensitivity induced by naproxen.
Gutiérrez-González E; Rodríguez-Pazos L; Rodríguez-Granados MT; Toribio J
Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):338-40. PubMed ID: 22092742
[TBL] [Abstract][Full Text] [Related]
57. Taxol: a new and effective anti-cancer drug.
Slichenmyer WJ; Von Hoff DD
Anticancer Drugs; 1991 Dec; 2(6):519-30. PubMed ID: 1687206
[TBL] [Abstract][Full Text] [Related]
58. Photo recall phenomenon: an adverse reaction to taxanes.
Ee HL; Yosipovitch G
Dermatology; 2003; 207(2):196-8. PubMed ID: 12920374
[TBL] [Abstract][Full Text] [Related]
59. Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading?
Spazzapan S; Crivellari D; Lombardi D; Scuderi C; Magri MD; Veronesi A; Gatti A
J Clin Oncol; 2002 Nov; 20(21):4404-5; author reply 4405. PubMed ID: 12409345
[No Abstract] [Full Text] [Related]
60. Cross-reactivity between paclitaxel and hazelnut: a case report.
Bukacel DG; Bander R; Ibrahim RB
J Oncol Pharm Pract; 2007 Mar; 13(1):53-5. PubMed ID: 17621569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
